FDA Inspection 1123946 — DSP
The FDA completed an inspection of DSP on June 27, 2019 in Chauny. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chauny (France)
Additional Details
Mutual Recognition Agreement (MRA)